Oregon Issues First Licenses For Psilocybin Facilitators

April 20, 2023 · Green Market Report

Oregon Health Authority (OHA)  released a statement on April 18 noting that the authority had licensed the state’s first three facilitators for providing psilocybin services. The licensing follows a regulatory framework created by M109, the Oregon Psilocybin Services Act. The OHA  said it issued the licenses to David Naftalin, Alexander Polvi and Jeanette Small.

“We want to congratulate the first facilitators to be licensed in Oregon,” says Oregon Psilocybin Services (OPS) Section Manager Angie Allbee. “As your work in providing non-directive psilocybin services takes shape, we thank you for your dedication to client safety and access as we move closer to opening service centers.”

In 2020, Oregonians passed Measure 109, the Oregon Psilocybin Services Act, which is now codified in Oregon law (ORS 475A). Oregon became the first state in the nation to implement a regulatory framework for the production of psilocybin products and the provision of psilocybin services. The Oregon Psilocybin Services (OPS) section is part of the Oregon Health Authority Public Health Division’s Center for Health Protection. OPS adopted final rules (OAR 333-333) in December 2022 and began accepting applications for four license types in January 2023, which include facilitator licenses, service center licenses, manufacturer licenses, and laboratory licenses.

The OHA stated that psilocybin administration sessions can only take place in licensed service centers statewide. These centers can employ and/or contract licensed facilitators trained to support preparation, administration, and integration sessions with clients. Service centers will provide psilocybin products produced by licensed manufacturers and tested by licensed laboratories. Currently, two manufacturers have licenses for producing psilocybin in the state. OPS anticipates issuing licenses to service center and laboratory applicants in the coming months.

The OHA also published a Psilocybin Resource Business Guide and the Oregon Psilocybin Advisory Board will be meeting again on May 5, 2023. At that time the board will review the following:
• Licensing Stats
• Letter to U.S. Attorney for Oregon
• Workday annual trainings
• Compensation

(Full Story)

In categories:Mushrooms Psychedelics
Tags:
Next Post

North Carolina Lawmakers File Bill To Create $5 Million Psychedelic Research Grant Fund

A Republican North Carolina lawmaker and a bipartisan group of cosponsors have filed a bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board…
Read
Previous Post

Conducting Study Using Psychedelics as Alcohol Use Disorder Treatment

University of Iowa (UI) researchers are conducting a pilot study using psilocybin and ketamine as a treatment for alcohol use disorder, the Daily Iowan reports. The study will be conducted as a head-to-head comparison of the compounds; half of the study participants…
Read
Random Post

DEA Official Says New Rules Are Coming For Synthetic Cannabinoids, Including CBD And Delta-8 THC

The Drug Enforcement Administration (DEA) will soon be proposing new rules to clarify that synthetically manufactured cannabinoids like delta-8 THC are prohibited controlled substances. At the agency’s 2023 Supply Chain Conference earlier this month, Terrance Boos, chief of DEA’s Drug…
Read
Random Post

Smoking Pot in College is Now Allowed for Athletes - NCAA May Soon Remove Cannabis from Drug Testing Panels

The Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) within the National Collegiate Athletics Association (NCAA) has proposed eliminating marijuana from the list of banned substances. The NCAA will seek feedback from its members during the summer and…
Read
Random Post

DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands

The Drug Enforcement Administration (DEA) is proposing a dramatic increase in its 2023 production quotas for marijuana compounds and psychedelics like psilocybin and ibogaine to “support research and clinical trials” into the substances. DEA wants to nearly double the amount…
Read
Random Post

Scotland Calls On UK To End ‘Failed’ Drug War With Decriminalization And Harm Reduction Approach

The Scottish government says that the war on drugs has “failed” and it’s time to decriminalize currently illicit substances, while promoting harm reduction services like overdose prevention centers. At a press conference on Friday, Scotland Drugs and Alcohol Policy Minister…
Read